Perdarahan Intrakranial Pasca Terapi Trombolisis Stroke Iskemik Akut pada Populasi Asia
DOI:
https://doi.org/10.37012/jik.v14i1.860Abstract
Terapi trombolisis dengan tPA (tissue Plasminogen Activator) merupakan terapi yang direkomendasikan pada stroke iskemik akut dengan onset kurang dari 4,5 jam. Namun terapi trombolisis memiliki komplikasi perdarahan intrakranial yang bervariasi di antara populasi diberbagai negara dan masih sedikitnya informasi perdarahan intrakranial pada populasi Asia. Penelitian dilakukan dengan metode kajian literature. Penelitian literature didapatkan dari data base online Google Scholar dan PubMed sesuai kriteria inklusi dan eksklusi ditemukan 11 artikel. Dari 11 artikel tersebut didapatkan pada populasi Asia perdarahan lebih tinggi jika menggunakan tPA dengan dosis standar dibanding dosis rendah. Beberapa faktor yang meningkatkan risiko perdarahan adalah derajat stroke, waktu pemberian tPA sejak onset gejala dan riwayat diabetes melitus. Perdarahan intrakanial merupakan salah satu komplikasi fatal yang penting pasca terapi trombolisis yang dapat meningkat seiring dengan faktor risiko tertentu, dan bervariasi antar studi di beberapa negara.
References
Albers GW & Olivot JM (2007). Intravenous alteplase for ischaemic stroke. Lancet, 369, 249-250
Dharmasaroja PA, Muengtaweepongsa S, Pattaraarchachai J & Dharmasaroja P (2012). Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke. J Clin Neurosci, 9, 799-803.
Emberson J. Stroke Thrombolysis Trialists' Collaborative Group (2014). Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet, 29, 384(9958),1929-35.
Feigin VL, Norrving B & Mensah GA (2017). Global Burden of Stroke. Circ Res,120(3), 439–48
GBD 2019 Diseases and Injuries Collaborators (2019). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396(10258),1204-1222
Hacke W; ECASS Investigators (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 359(13, 1317-29.
Liu M, Pan Y, Zhou L & Wang Y (2017). Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke. PLoS One, 12(9), e0184646.
Nakagawara J et al. J-MARS Investigators (2010). Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke, 41(9), 1984-9
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995). Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 333(24),1581-7.
Park TH (2014). The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients. J Stroke Cerebrovasc Dis, 23(2), 367-73.
Saver JL (2006). Time Is Brain--Quantified. Stroke, 37(1), 263–6
Schwamm LH, Ali SF & Reeves MJ (2013). Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes, 6, 543–549.
Strbian D (2012). Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol, 71(5), 634-41
Suengtaworn A, Saposnik G, Hurst CP, Poungvarin N & Nilanont Y (2019). Accuracy of Clinical Risk Scores in Predicting Post-rtPA Intracerebral Hemorrhage in a Thai Cohort. J Med Assoc Thai. 102(5):1-7.
Tai MLS, Goh KJ, Kadir KAA, Zakaria MI, Yap JF & Tan KS (2019). Predictors of functional outcome in patients with stroke thrombolysis in a tertiary hospital in Malaysia. Singapore Med J. 60(5):236-240.
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Jurnal Ilmiah Kesehatan allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The journal allows the author(s) to hold the copyright without restrictions. Finally, the journal allows the author(s) to retain publishing rights without restrictions Authors are allowed to archive their submitted article in an open access repository Authors are allowed to archive the final published article in an open access repository with an acknowledgment of its initial publication in this journal.
Lisensi Creative Commons Atribusi 4.0 Internasional.
